Table 1.

Test performance and Disease prevalence estimates

Test characteristics	Sensitivity	Specificity	Reference
Standard of care	0.35	0.65	Expert Opinion [16, 17]
FIB-4 (cut off 1.30)	0.84	0.74	[18, 19]
FIB-4 (cut off 3.25)	0.38	0.97	[18, 19]
ELF	0.80	0.90	[19, 20]
Fibroscan	0.82	0.84	[19, 21]
Population and disease characteristics	Transition probability
Prevalence of advanced fibrosis in the general population	0.075		[5]

Published test characteristics of non-invasive liver fibrosis tests to detect advanced fibrosis (METAVIR ≥F3) in patients with non-alcoholic fatty liver disease